Overview

A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This randomized, open-label, cross-over study will assess the bioavailability and safety of RO4995819 in healthy volunteers. Volunteers will receive two different formulations (tablet and capsule) of the study drug under fed and fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Hoffmann-La Roche